Oncology

Chronic Graft-versus-Host Disease

Expert Perspectives in Chronic Graft-versus-Host Disease to Cover Key Topics in Chronic Graft-versus-Host Disease Treatment

expert perspectives by Corey Cutler, MD, MPH, FRCP(C); Daniel R. Couriel, MD, MS; Sergio A. Giralt, MD

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. This issue of Expert Perspectives in Chronic Graft-versus-Host Disease will feature selected topics in cGVHD that we hope you will find of value in your clinical practice.

The clinicians who were surveyed selected the following experts and topics.

Community-Selected Experts:

Daniel R. Couriel, MD, MS

Professor of Internal Medicine
HCI Chair for Adult Leukemia Research
Director, Utah Blood and Marrow Transplant Program
Medical Director, Center for Cellular Therapy and Regenerative Medicine
Division of Hematology and Hematologic Malignancies
Huntsman Cancer Institute
University of Utah School of Medicine
Salt Lake City, UT

Corey Cutler,, MD, MPH, FRCPC

Medical Director, Stem Cell Transplantation Program
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Sergio A. Giralt, MD

Deputy Division Head
Division of Hematologic Malignancies
Melvin Berlin Family Chair in Multiple Myeloma
Memorial Sloan Kettering Cancer Center
New York, NY

Community-Selected Topics:

Expert Roundtables

•   Optimizing the Chronic Graft-versus-Host Disease Treatment Paradigm
•   Chronic Graft-versus-Host Disease: Current Challenges and Opportunities
•   Refractory Chronic Graft-versus-Host Disease: Management and Monitoring Recommendations
•   Preventing and Treating Chronic Graft-versus-Host Disease Without Compromising Antitumor Effects

Clinical Topic Updates

•   Refractory Chronic Graft-versus-Host Disease: Choosing Immunosuppressive/Immunomodulating Agents
•   Screening for Chronic Graft-versus-Host Disease–Associated Comorbidities
•   Updates on Preventive Measures for Chronic Graft-versus-Host Disease
•   Targeting Cytokine Pathways in Chronic Graft-versus-Host Disease: Drivers of Fibrosis and Inflammation

Patient Care Perspectives

•   Tailoring Care to Organ-Specific Manifestations of Chronic Graft-versus-Host Disease
•   Principles of Multispecialty Care for Refractory Chronic Graft-versus-Host Disease
•   Patients With Ongoing Chronic Graft-versus-Host Disease: Tracking and Adjusting Treatment
•   Role of Adjunctive Nonsystemic Therapies in Chronic Graft-versus-Host Disease

Profile

Corey Cutler, MD, MPH, FRCP(C)

Director, Stem Cell Transplantation Program
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, MA

Profile

Daniel R. Couriel, MD, MS

Profile

Sergio A. Giralt, MD

Deputy Division Head
Division of Hematologic Malignancies
Melvin Berlin Family Chair in Multiple Myeloma
Memorial Sloan Kettering Cancer Center
New York, NY

Oncology

Chronic Graft-versus-Host Disease

Expert Perspectives in Chronic Graft-versus-Host Disease to Cover Key Topics in Chronic Graft-versus-Host Disease Treatment

Overview

Daniel R. Couriel, MD, MS

Corey Cutler,, MD, MPH, FRCPC

Sergio A. Giralt, MD

Corey Cutler, MD, MPH, FRCP(C)

Daniel R. Couriel, MD, MS

Sergio A. Giralt, MD

Explore More in Chronic Graft-versus-Host Disease

Novel Approaches to Graft-versus-Host Disease Prophylaxis: Recent Progress and Future Directions

Expert Roundtables Podcast: New Approaches to Treatment and the Importance of Add-On Therapy for Chronic Graft-versus-Host Disease

Chronic Graft-versus-Host Disease–Related Nonrelapse Mortality and Morbidity

Can Chronic Graft-versus-Host Disease Be Prevented?